Srija Sur

712 total citations · 1 hit paper
8 papers, 528 citations indexed

About

Srija Sur is a scholar working on Biomaterials, Plant Science and Biomedical Engineering. According to data from OpenAlex, Srija Sur has authored 8 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Biomaterials, 2 papers in Plant Science and 2 papers in Biomedical Engineering. Recurrent topics in Srija Sur's work include Nanoparticle-Based Drug Delivery (2 papers), Biofuel production and bioconversion (2 papers) and Nanoparticles: synthesis and applications (2 papers). Srija Sur is often cited by papers focused on Nanoparticle-Based Drug Delivery (2 papers), Biofuel production and bioconversion (2 papers) and Nanoparticles: synthesis and applications (2 papers). Srija Sur collaborates with scholars based in India, Malaysia and Australia. Srija Sur's co-authors include Vivek Dave, Veera Sadhu, Kakarla Raghava Reddy, Raghuraj Singh Chouhan, Aishwarya Rathore, Rekha Sharma, S.J.S. Flora, Mohini Chaurasia, Suvadra Das and Prashansa Sharma and has published in prestigious journals such as Journal of Chromatography A, Colloids and Surfaces B Biointerfaces and Frontiers in Pharmacology.

In The Last Decade

Srija Sur

8 papers receiving 514 citations

Hit Papers

Recent developments in functionalized polymer nanoparticl... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Srija Sur India 6 191 144 119 109 88 8 528
Huizhu Zhang China 15 199 1.0× 126 0.9× 100 0.8× 192 1.8× 101 1.1× 37 722
Veronika Mikušová Slovakia 8 197 1.0× 94 0.7× 152 1.3× 116 1.1× 65 0.7× 19 502
Emmanuel Chekwube Ossai Nigeria 7 150 0.8× 165 1.1× 96 0.8× 144 1.3× 66 0.8× 16 528
Azzah M. Bannunah Saudi Arabia 10 132 0.7× 124 0.9× 119 1.0× 186 1.7× 115 1.3× 16 553
Zoran Lavrič Slovenia 11 221 1.2× 152 1.1× 139 1.2× 121 1.1× 117 1.3× 23 708
Andreea Loredana Vonica-Țincu Romania 7 153 0.8× 122 0.8× 73 0.6× 188 1.7× 62 0.7× 23 706
J. Jeslin India 4 184 1.0× 136 0.9× 65 0.5× 126 1.2× 71 0.8× 7 437
André O’Reilly Beringhs United States 15 103 0.5× 133 0.9× 184 1.5× 121 1.1× 96 1.1× 33 590
Seyedeh Sara Esnaashari Iran 15 337 1.8× 266 1.8× 91 0.8× 154 1.4× 97 1.1× 20 694

Countries citing papers authored by Srija Sur

Since Specialization
Citations

This map shows the geographic impact of Srija Sur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srija Sur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srija Sur more than expected).

Fields of papers citing papers by Srija Sur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srija Sur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srija Sur. The network helps show where Srija Sur may publish in the future.

Co-authorship network of co-authors of Srija Sur

This figure shows the co-authorship network connecting the top 25 collaborators of Srija Sur. A scholar is included among the top collaborators of Srija Sur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srija Sur. Srija Sur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Chaurasia, Mohini, et al.. (2023). A review of FDA approved drugs and their formulations for the treatment of breast cancer. Frontiers in Pharmacology. 14. 1184472–1184472. 36 indexed citations
2.
Prakash, Anand, Srija Sur, Vivek Dave, et al.. (2023). Green synthesized cobalt nanoparticles from Trianthema portulacastrum L. as a novel antimicrobials and antioxidants. Preparative Biochemistry & Biotechnology. 54(3). 1–15. 9 indexed citations
3.
Roy, Partha, Srija Sur, Suvadra Das, & Wong Tin Wui. (2022). Phytochemical-conjugated bio-safe gold nanoparticles in breast cancer: a comprehensive update. Breast Cancer. 29(5). 761–777. 8 indexed citations
4.
Dave, Vivek, et al.. (2020). Folic acid modified gold nanoparticle for targeted delivery of Sorafenib tosylate towards the treatment of diabetic retinopathy. Colloids and Surfaces B Biointerfaces. 194. 111151–111151. 44 indexed citations
5.
Sur, Srija, et al.. (2020). Expansion and scale up of technology for ethanol production based on the concept of biorefinery. Journal of Food Process Engineering. 44(2). 5 indexed citations
6.
Dave, Vivek, et al.. (2020). Vivid techniques of pretreatment showing promising results in biofuel production and food processing. Journal of Food Process Engineering. 44(2). 3 indexed citations
7.
Sur, Srija, Aishwarya Rathore, Vivek Dave, et al.. (2019). Recent developments in functionalized polymer nanoparticles for efficient drug delivery system. Nano-Structures & Nano-Objects. 20. 100397–100397. 388 indexed citations breakdown →
8.
Sur, Srija, et al.. (1991). Gas chromatographic determination of monoterpenes in essential oil medicinal plants. Journal of Chromatography A. 542. 451–458. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026